|
1
|
Chan SY and Loscalzo J: Pathogenic
mechanisms of pulmonary arterial hypertension. J Mol Cell Cardiol.
44:14–30. 2008. View Article : Google Scholar :
|
|
2
|
Humbert M, Sitbon O and Simonneau G:
Treatment of pulmonary arterial hypertension. N Engl J Med.
351:1425–1436. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Archer S and Rich S: Primary pulmonary
hypertension: A vascular biology and translational research 'Work
in progress'. Circulation. 102:2781–2791. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
De Caestecker M and Meyrick B: Bone
morphogenetic proteins, genetics and the pathophysiology of primary
pulmonary hypertension. Respir Res. 2:193–197. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Stenmark KR and Mecham RP: Cellular and
molecular mechanisms of pulmonary vascular remodeling. Annu Rev
Physiol. 59:89–144. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Voelkel NF and Tuder RM: Cellular and
molecular biology of vascular smooth muscle cells in pulmonary
hypertension. Pulm Pharmacol Ther. 10:231–241. 1997. View Article : Google Scholar
|
|
7
|
McMurtry MS, Bonnet S, Wu X, Dyck JR,
Haromy A, Hashimoto K and Michelakis ED: Dichloroacetate prevents
and reverses pulmonary hypertension by inducing pulmonary artery
smooth muscle cell apoptosis. Circ Res. 95:830–840. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Derynck R, Zhang Y and Feng XH: Smads:
Transcriptional activators of TGF-beta responses. Cell. 95:737–740.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Derynck R and Zhang YE: Smad-dependent and
Smad-independent pathways in TGF-beta family signalling. Nature.
425:577–584. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shi Y and Massagué J: Mechanisms of
TGF-beta signaling from cell membrane to the nucleus. Cell.
113:685–700. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Agrotis A, Kalinina N and Bobik A:
Transforming growth factor-beta, cell signaling and cardiovascular
disorders. Curr Vasc Pharmacol. 3:55–61. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bartram U and Speer CP: The role of
transforming growth factor beta in lung development and disease.
Chest. 125:754–765. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xu YD, Hua J, Mui A, O'Connor R,
Grotendorst G and Khalil N: Release of biologically active
TGF-beta1 by alveolar epithelial cells results in pulmonary
fibrosis. Am J Physiol Lung Cell Mol Physiol. 285:L527–L539. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Rabinovitch M: The mouse through the
looking glass: A new door into the pathophysiology of pulmonary
hypertension. Circ Res. 94:1001–1004. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Arcot SS, Lipke DW, Gillespie MN and Olson
JW: Alterations of growth factor transcripts in rat lungs during
development of monocrotaline-induced pulmonary hypertension.
Biochem Pharmacol. 46:1086–1091. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Morrell NW, Yang X, Upton PD, Jourdan KB,
Morgan N, Sheares KK and Trembath RC: Altered growth responses of
pulmonary artery smooth muscle cells from patients with primary
pulmonary hypertension to transforming growth factor-beta(1) and
bone morphogenetic proteins. Circulation. 104:790–795. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lu Q: Transforming growth factor-beta1
protects against pulmonary artery endothelial cell apoptosis via
ALK5. Am J Physiol Lung Cell Mol Physiol. 295:L123–L133. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mauro M, Kim J, Costello C and Laurence J:
Role of transforming growth factor beta1 in microvascular
endothelial cell apoptosis associated with thrombotic
thrombocytopenic purpura and hemolytic-uremic syndrome. Am J
Hematol. 66:12–22. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Datta SR, Brunet A and Greenberg ME:
Cellular survival: A play in three Akts. Genes Dev. 13:2905–2927.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Downward J: Mechanisms and consequences of
activation of protein kinase B/Akt. Curr Opin Cell Biol.
10:262–267. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo
P, Hu LS, Anderson MJ, Arden KC, Blenis J and Greenberg ME: Akt
promotes cell survival by phosphorylating and inhibiting a Forkhead
transcription factor. Cell. 96:857–868. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li Y, Song YH, Mohler J and Delafontaine
P: ANG II induces apoptosis of human vascular smooth muscle via
extrinsic pathway involving inhibition of Akt phosphorylation and
increased FasL expression. Am J Physiol Heart Circ Physiol.
290:H2116–H2123. 2006. View Article : Google Scholar
|
|
23
|
Wang XQ, Sun P and Paller AS: Inhibition
of integrin-linked kinase/protein kinase B/Akt signaling: Mechanism
for ganglioside-induced apoptosis. J Biol Chem. 276:44504–44511.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Garat CV, Fankell D, Erickson PF, Reusch
JEB, Bauer NN, McMurtry IF and Klemm DJ: Platelet-derived growth
factor BB induces nuclear export and proteasomal degradation of
CREB via phosphatidylinositol 3-kinase/Akt signaling in pulmonary
artery smooth muscle cells. Mol Cell Biol. 26:4934–4948. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang L, Ma J, Li Y, Guo L, Ran Y, Liu S,
Jiang C and Zhu D: 15-Hydroxyeicosatetraenoic acid (15-HETE)
protects pulmonary artery smooth muscle cells against apoptosis via
HSP90. Life Sci. 87:223–231. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ma J, Liang S, Wang Z, Zhang L, Jiang J,
Zheng J, Yu L, Zheng X, Wang R and Zhu D: ROCK pathway participates
in the processes that 15-hydroxyeicosatetraenoic acid (15-HETE)
mediated the pulmonary vascular remodeling induced by hypoxia in
rat. J Cell Physiol. 222:82–94. 2010. View Article : Google Scholar
|
|
27
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
28
|
Ma J, Zhang L, Han W, Shen T, Ma C, Liu Y,
Nie X, Liu M, Ran Y and Zhu D: Activation of JNK/c-Jun is required
for the proliferation, survival, and angiogenesis induced by EET in
pulmonary artery endothelial cells. J Lipid Res. 53:1093–105. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang Z, Tang X, Li Y, Leu C, Guo L, Zheng
X and Zhu D: 20-Hydroxyeicosatetraenoic acid inhibits the apoptotic
responses in pulmonary artery smooth muscle cells. Eur J Pharmacol.
588:9–17. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kobayashi T, Masumoto J, Tada T, Nomiyama
T, Hongo K and Nakayama J: Prognostic significance of the
immunohistochemical staining of cleaved caspase-3, an activated
form of caspase-3, in gliomas. Clin Cancer Res. 13:3868–3874. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Adams JM and Cory S: The Bcl-2 protein
family: Arbiters of cell survival. Science. 281:1322–1326. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li L, Xu M, Li X, Lv C, Zhang X, Yu H,
Zhang M, Fu Y, Meng H and Zhou J: Platelet-derived growth factor-B
(PDGF-B) induced by hypoxia promotes the survival of pulmonary
arterial endothelial cells through the PI3K/Akt/Stat3 pathway. Cell
Physiol Biochem. 35:441–451. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Mandegar M, Fung YC, Huang W, Remillard
CV, Rubin LJ and Yuan JX: Cellular and molecular mechanisms of
pulmonary vascular remodeling: Role in the development of pulmonary
hypertension. Microvasc Res. 68:75–103. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Pidgeon GP, Tamosiuniene R, Chen G,
Leonard I, Belton O, Bradford A and Fitzgerald DJ: Intravascular
thrombosis after hypoxia-induced pulmonary hypertension: Regulation
by cyclooxygenase-2. Circulation. 110:2701–2707. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhang S, Fantozzi I, Tigno DD, Yi ES,
Platoshyn O, Thistlethwaite PA, Kriett JM, Yung G, Rubin LJ and
Yuan JX: Bone morphogenetic proteins induce apoptosis in human
pulmonary vascular smooth muscle cells. Am J Physiol Lung Cell Mol
Physiol. 285:L740–L754. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Gibbons GH and Dzau VJ: The emerging
concept of vascular remodeling. N Engl J Med. 330:1431–1438. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Uhal BD: Apoptosis in lung fibrosis and
repair. Chest. 122(Suppl): 293S–298S. 2002. View Article : Google Scholar : PubMed/NCBI
|
